| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
3,615 |
3,395 |
$612K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
1,252 |
1,192 |
$209K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
240 |
225 |
$96K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
576 |
539 |
$87K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
507 |
479 |
$80K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
166 |
134 |
$24K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
327 |
315 |
$9K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
437 |
386 |
$9K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
388 |
119 |
$8K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
523 |
468 |
$6K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
71 |
24 |
$5K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
36 |
32 |
$3K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
523 |
468 |
$3K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
2,748 |
2,448 |
$2K |
| 80053 |
Comprehensive metabolic panel |
1,954 |
1,775 |
$2K |
| 84443 |
Thyroid stimulating hormone (TSH) |
239 |
232 |
$2K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
81 |
26 |
$2K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
377 |
337 |
$2K |
| 87081 |
|
255 |
229 |
$2K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
16 |
13 |
$1K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
112 |
101 |
$1K |
| 36415 |
Collection of venous blood by venipuncture |
773 |
700 |
$1K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
111 |
101 |
$793.66 |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
498 |
466 |
$745.12 |
| 80050 |
General health panel |
52 |
50 |
$505.95 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
54 |
51 |
$454.00 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
103 |
94 |
$378.55 |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
13 |
12 |
$303.49 |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
226 |
211 |
$285.26 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
127 |
118 |
$248.28 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
161 |
145 |
$201.62 |
| 86780 |
|
28 |
27 |
$137.34 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
29 |
28 |
$113.60 |
| 86762 |
|
16 |
15 |
$100.50 |
| 82247 |
|
16 |
12 |
$78.72 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
29 |
28 |
$71.31 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
296 |
265 |
$54.00 |
| 81001 |
|
468 |
436 |
$50.96 |
| 86850 |
|
13 |
12 |
$43.49 |
| 36416 |
|
17 |
12 |
$39.78 |
| 71046 |
Radiologic examination, chest; 2 views |
27 |
26 |
$34.96 |
| 86803 |
|
16 |
15 |
$31.68 |
| 87807 |
|
16 |
16 |
$27.62 |
| 83605 |
|
62 |
52 |
$24.87 |
| 86900 |
|
13 |
12 |
$21.79 |
| 86901 |
|
13 |
12 |
$10.90 |
| 83690 |
|
137 |
126 |
$5.00 |
| 81003 |
|
16 |
16 |
$0.00 |
| 82248 |
|
104 |
86 |
$0.00 |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
251 |
211 |
$0.00 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
46 |
39 |
$0.00 |
| 85610 |
|
30 |
26 |
$0.00 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
15 |
15 |
$0.00 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
16 |
14 |
$0.00 |
| 81025 |
|
25 |
25 |
$0.00 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
14 |
12 |
$0.00 |
| 80306 |
|
13 |
13 |
$0.00 |
| J3490 |
Unclassified drugs |
4,531 |
2,729 |
$0.00 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
71 |
66 |
$0.00 |
| 71045 |
Radiologic examination, chest; single view |
115 |
96 |
$0.00 |
| 84484 |
|
53 |
38 |
$0.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
64 |
59 |
$0.00 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
15 |
14 |
$0.00 |
| 87430 |
|
12 |
12 |
$0.00 |
| 85730 |
|
12 |
12 |
$0.00 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
13 |
13 |
$0.00 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
26 |
24 |
$0.00 |